BioHealth News

Raymond Blanchard, Associate Director of IP & Licensing with QIAGEN, visits BioTalk

Raymond Blanchard, Associate Director of IP & Licensing with QIAGEN, visits BioTalk

QIAGEN Associate Director of IP & Licensing, Raymond Blanchard, chats with Rich Bendis on BioTalk to discuss innovation, intellectual property and having a large…

Read More
Darryll J. Pines, President, University of Maryland, Visits with Rich Bendis on BioTalk

Darryll J. Pines, President, University of Maryland, Visits with Rich Bendis on BioTalk

Darryll J. Pines, President, University of Maryland, Joins BioTalk to discuss all things relating the University to the BioHealth Capital Region from Quantum to…

Read More
Dr. Ken Malone, Co-Founder and Managing Director of Early Charm Ventures, Visits BioTalk

Dr. Ken Malone, Co-Founder and Managing Director of Early Charm Ventures, Visits BioTalk

Ken Malone, Co-Founder and Managing Director of Early Charm Ventures, Joins BioTalk to discuss his career path, loving Baltimore, and what he sees as…

Read More
Ron Kurz, Sr. Director & GM at Canon Virginia, Inc., visits the BioTalk Podcast

Ron Kurz, Sr. Director & GM at Canon Virginia, Inc., visits the BioTalk Podcast

Ron Kurz, Sr. Director & GM at Canon Virginia, Inc., joins BioTalk to discuss his career, growth opportunities, and Canon’s role in the BioHealth…

Read More
Maryland Tech Council CEO Marty Rosendale joins Rich Bendis on BioTalk

Maryland Tech Council CEO Marty Rosendale joins Rich Bendis on BioTalk

Marty Rosendale, Chief Executive Officer of the Maryland Tech Council, joins BioTalk to discuss MTCs Programs, Accessing Capital, and Goals for 2022 Listen now…

Read More
United States Pharmacopeia CEO Ron Piervincenzi, Ph.D., returns to BioTalk

United States Pharmacopeia CEO Ron Piervincenzi, Ph.D., returns to BioTalk

Ron Piervincenzi, Ph.D., CEO of United States Pharmacopeia, sits down with host, Rich Bendis, to discuss USP’s growth since his last visit, the nature…

Read More
Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, joins BioTalk

Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, joins BioTalk

Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, visits Rich Bendis to discuss his career from NIH, to CEO of Avidea, to their merger with Vaccitech.…

Read More
Vaccitech CEO Bill Enright Joins Rich Bendis on First BioTalk of 2022

Vaccitech CEO Bill Enright Joins Rich Bendis on First BioTalk of 2022

Bill visits BioTalk to talk about being a serial entrepreneur, biotech executive, and their recent acquisition of Avidea Technologies. Listen now via Apple https://apple.co/3fTySQM, Google https://bit.ly/3KDPMkh,…

Read More
BioTalk Welcomes Ellington West, CEO & Co-founder of Sonavi Labs

BioTalk Welcomes Ellington West, CEO & Co-founder of Sonavi Labs

Ellington West, CEO & Co-founder of Sonavi Labs, joins BioTalk to discuss their building the startup, their medical device, and raising funds in the…

Read More
BioTalk Welcomes Amritha Jaishankar, PhD, Executive Director, Maryland Stem Cell Research Fund (MSCRF)

BioTalk Welcomes Amritha Jaishankar, PhD, Executive Director, Maryland Stem Cell Research Fund (MSCRF)

Amritha Jaishankar, PhD, Executive Director, Maryland Stem Cell Research Fund (MSCRF), joins BioTalk to discuss her career, investing in Maryland, and accelerating cures.  …

Read More
BioTalk Welcomes Mr. Hakdo Kim, President, Korea SMEs & Startups Agency KOSME)

BioTalk Welcomes Mr. Hakdo Kim, President, Korea SMEs & Startups Agency KOSME)

Mr. Hakdo Kim, President, Korea SMEs & Startups Agency KOSME), joins Rich Bendis from the BHI Offices to discuss their biotech mission, their relationship…

Read More
A US – UK Discussion: How to Conduct Clinical Trials as Seth Toback, Vice President, Clinical Development at Novavax and Divya Chadha Manek, Director of Business Development at the National Institute for Health Research (NIHR) join Rich Bendis on BioTalk.

A US – UK Discussion: How to Conduct Clinical Trials as Seth Toback, Vice President, Clinical Development at Novavax and Divya Chadha Manek, Director of Business Development at the National Institute for Health Research (NIHR) join Rich Bendis on BioTalk.

Listen now via Apple https://apple.co/3BSIFjn, Google https://bit.ly/3j7YyLt, Spotify https://spoti.fi/2Z474Ec, and TuneIn https://bit.ly/3DUweUz. Divya Chadha Manek was appointed as the NIHR CRN’s Head of Commercial Business Development in 2015 then…

Read More
BioHealth Capital Region Forum Recap – GEN Top 10 BioPharma Clusters Update

BioHealth Capital Region Forum Recap – GEN Top 10 BioPharma Clusters Update

Alex Philippidis, Senior Business Editor of Genetic Engineering and Biotechnology News, returned to the Forum to give his annual update on the GEN rankings…

Read More
From the 7th Annual BioHealth Capital Region Forum – Dr. Tara Schwetz, Assistant Director for Biomedical Science Initiatives, White House Office of Science and Technology Policy (OSTP)

From the 7th Annual BioHealth Capital Region Forum – Dr. Tara Schwetz, Assistant Director for Biomedical Science Initiatives, White House Office of Science and Technology Policy (OSTP)

Listen now via Google https://bit.ly/3EWtTtJ, Apple https://apple.co/3ocpP2w, Spotify https://spoti.fi/3EUALYu, and TuneIn https://bit.ly/3CGZ8Ho. The session from the BioHealth Capital Region Forum focuses on a vision for a new science…

Read More
BioTalk: From the 7th Annual BioHealth Capital Region Forum – Dr. Anthony Fauci

BioTalk: From the 7th Annual BioHealth Capital Region Forum – Dr. Anthony Fauci

Listen to the audio as Rich Bendis, President and CEO of BioHealth Innovation conducts a fireside chat with Dr. Anthony Fauci, Director of the…

Read More